# Yongjun Zhao

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yongjun-zhao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,959 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 59 |
| i10-index | 117 |
| Last Known Institution | Canada's Michael Smith Genome Sciences Centre |
| OpenAlex ID | https://openalex.org/A5044705149 |
| ORCID iD | https://orcid.org/0000-0001-7380-3806 |
| Works | 234 |

## Researcher papers

- [The clonal and mutational evolution spectrum of primary triple-negative breast cancers](https://scholariq.org/papers/the-clonal-and-mutational-evolution-spectrum-of-primary-triple-negative-breast/)
- [<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas](https://scholariq.org/papers/i-arid1a-i-mutations-in-endometriosis-associated-ovarian-carcinomas/)
- [Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin](https://scholariq.org/papers/somatic-mutations-altering-ezh2-tyr641-in-follicular-and-diffuse-large-b-cell/)
- [Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution](https://scholariq.org/papers/mutational-evolution-in-a-lobular-breast-tumour-profiled-at-single-nucleotide/)
- [Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary](https://scholariq.org/papers/mutation-of-i-foxl2-i-in-granulosa-cell-tumors-of-the-ovary/)
- [Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution](https://scholariq.org/papers/dynamics-of-genomic-clones-in-breast-cancer-patient-xenografts-at-single-cell/)
- [MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers](https://scholariq.org/papers/mhc-class-ii-transactivator-ciita-is-a-recurrent-gene-fusion-partner-in-lymphoid/)
- [Concurrent <i>CIC</i> mutations, <i>IDH</i> mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers](https://scholariq.org/papers/concurrent-i-cic-i-mutations-i-idh-i-mutations-and-1p-19q-loss-distinguish/)
- [Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer](https://scholariq.org/papers/homologous-recombination-deficiency-and-platinum-based-therapy-outcomes-in/)
- [Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes](https://scholariq.org/papers/pan-cancer-analysis-of-advanced-patient-tumors-reveals-interactions-between/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genomics and Phylogenetic Studies](https://scholariq.org/topics/genomics-and-phylogenetic-studies/)
- [Cryptography and Data Security](https://scholariq.org/topics/cryptography-and-data-security/)
- [Privacy-Preserving Technologies in Data](https://scholariq.org/topics/privacy-preserving-technologies-in-data/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [Canada's Michael Smith Genome Sciences Centre](https://scholariq.org/institutions/canada-s-michael-smith-genome-sciences-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.